Our recently secured oversubscribed #SeriesA financing will support SPEAR development for #neurology and other disease research applications, as we continue to redefine #biomarker detection for precision medicine. Learn More: If you’re attending #AAIC24, there’s still time to visit booth 740 to learn more about our technology and the work we’re doing with NfL and pTau 217! #ENDALZ #Alzheimer’s #neurology #precisionmedicine #neuroscience #SeriesA #biotech
Congratulations!!
Congrats!
Democratizing clinical genomics to improve healthcare in the genome era.
4 个月Congrats Feng Xuan and team!